4Saudubray JM, Nassogne MC, de Lonlay P, Touati G. Clinical approach to inherited metabolic disorders in neonates: an overview[J]. Semin Neonatol, 2002, 7(1): 3-15.
5Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis[J]. Pediatrics, 1998, 102(6): E69.
6Jones PM, Bannett MJ. The changing face of newborn screening:diagnosis of inborn errors of metabolism by tandem mass spectrometry[J]. Clin Chim Acta, 2002, 324(1-2) :121 - 128.
7Fu X, Iga M, Kimura M,Yamaguchi S. Simplified screening for organic acidemia using GC/MS and dried urine filter paper: a study on neonatal mass screening[J]. Early Hum Dev, 2000, 58(1): 41-55.
8Charkrapani A, Cleary MA, Wraith JE. Detection of inborn errors of metabolism in the newborn [J]. Arch Dis Child Fetal Neonatal Ed, 2001, 84(3): F205-F210.
10Grompe M. The pathophysiology and treatment of hereditary tyrosinemia type I [J]. Semin Liver Dis, 2001, 21 (4): 563-571.
二级参考文献33
1Kayler LK, Merion RM, Lee S, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant, 2002, 6: 295-300.
2Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.Science, 2002, 296: 2410-2413.
3Cabrera-Salazar MA, Novelli E, Barranger JA. Gene therapy for the lysosomal storage disorders. Curt Opin Mol Ther, 2002, 4:349-358.
4Ding EY, Hodges BL, Hu H, et al. Long-term efficacy after [El-,polymerase-] adenovirus-medlated trander of htlman acid-alpha-glucosidase gene into glycogen storage disease type Ⅱ knockout mice.Hum Gene Ther, 2001, 12: 955-965.
5Lyon G, Adams RD, Koiodny EH. eds. Neurology of hereditary metabolic disease of children. 2nd ed. New York: McGraw-Hill,1996.352-363.
6Scriver CR, Beaudet AL, Sly WS, et al. eds. The metabolic and molecular bases of inherited diseases. 8th ed. New York : McGraw-Hill, 2001.1-100.
7Clarke JTR. ed. A clinical guide to inherited metabolic diseases. 2nd ed. Cambridge: Cambridge university Press, 2002. 255-273.
8Meli C, Bianca S. Dietary control of phenylketonuria. Lancet,2002,360 : 2075-2076.
9MacDonald A. Diet and compliance in phenylketonuria. Eur J Pediatr, 2000, 159 (Suppl 2) : S136-S141.
10Coumley-Martin G, Bross R, Rafli M, et al. Phenylalanine requirement in children with classical phenylketonuria determined by indicator amino acid oxidation. Am J Physiol Endocrinol Metab,2002, 283 : E1249-1256.
